Biogen ROA Ratio 2011-2026 | BIIB

Annual ROA Ratio Biogen

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
4.39	5.82	4.33	12.41	6.52	16.25	21.62	17.52	10.73	16.19	18.19	20.5	15.7	13.62	13.64

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
21.62	4.33	13.16

Quarterly ROA Ratio Biogen

2025-Q2	2025-Q1	2024-Q3	2024-Q2	2024-Q1	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
6.65	5.89	4.79	5.77	5.17	8.25	13.06	14.93	10.07	11.45	8.27	5.88	6.81	8.27	9.73	14.16	16.25	20.08	22.91	22.13	21.62	20.08	20.11	18.06	17.52	12.52	11.99	12.21	10.73	14.83	14.16	15.1	16.19	17.61	18.05	18.21	18.19	20.09	21.13	21.37	20.5	18.18	16.31	15.45	15.7	14.73	14.55	14.23	13.62	14.06	14.01	13.38	13.64	3.89	3.18	3.25

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
22.91	3.18	13.73

ROA Ratio of other stocks in the Biotechnology industry

Issuer	ROA Ratio	Price	% 24h	Market Cap	Country
Precigen PGEN	-161.18	$ 3.1	-0.96 %	$ 758 M	USA
MorphoSys AG MOR	-20.13	-	2.43 %	$ 254 M	Germany
ARCA biopharma ABIO	-21.14	-	1052.0 %	$ 415 M	USA
Aeterna Zentaris AEZS	-10.45	-	5.93 %	$ 314 M	Canada
Akero Therapeutics AKRO	-30.52	-	-	$ 3.67 B	USA
Akouos AKUS	-31.09	-	0.23 %	$ 488 M	USA
I-Mab IMAB	7.43	-	-	$ 866 M	China
Alexion Pharmaceuticals, Inc. ALXN	3.33	-	-	$ 40.3 B	USA
Genfit SA GNFT	23.87	-	2.54 %	$ 160 B	France
Albireo Pharma ALBO	-11.27	-	-0.23 %	$ 916 M	USA
Biophytis SA BPTS	-89.6	-	-13.47 %	$ 169 M	France
Ascendis Pharma A/S ASND	-35.36	$ 220.9	2.49 %	$ 5 B	Danmark
Aileron Therapeutics ALRN	-101.11	-	10.36 %	$ 9.8 M	USA
Midatech Pharma plc MTP	-42.28	-	-18.52 %	$ 27.3 M	Britain
EyeGate Pharmaceuticals, Inc. EYEG	-53.39	-	-1.52 %	$ 24.7 M	USA
Applied Genetic Technologies Corporation AGTC	-27.57	-	-	$ 26.5 M	USA
Amphastar Pharmaceuticals AMPH	6.02	$ 19.57	1.77 %	$ 915 M	USA
AgeX Therapeutics AGE	-275.96	-	-10.17 %	$ 12.2 K	USA
Aptinyx APTX	-97.25	-	-39.0 %	$ 4.57 M	USA
Acorda Therapeutics ACOR	-232.99	-	-24.86 %	$ 820 K	USA
Acasti Pharma ACST	-13.29	-	4.01 %	$ 150 M	Canada
Институт стволовых клеток человека ISKJ	4.82	-	-	-	Russia
Adverum Biotechnologies ADVM	-72.8	-	-	$ 86.2 M	USA
Acer Therapeutics ACER	-225.71	-	2.71 %	$ 14 M	USA
Advaxis ADXS	-289.96	-	-9.65 %	$ 45.9 M	USA
Ayala Pharmaceuticals AYLA	-489.29	-	-	$ 7.46 M	Israel
Avenue Therapeutics ATXI	-437.72	-	-52.27 %	$ 4.45 M	USA
Autolus Therapeutics plc AUTL	-28.19	$ 1.33	0.76 %	$ 339 M	Britain
Atreca BCEL	-62.67	-	-11.76 %	$ 5.79 M	USA
BeiGene, Ltd. BGNE	3.5	-	0.49 %	$ 251 B	Cayman-islands
bluebird bio BLUE	-34.23	-	-	$ 546 M	USA
ProQR Therapeutics N.V. PRQR	-29.43	$ 1.58	6.04 %	$ 99.5 M	Niderland
BioDelivery Sciences International BDSI	26.14	-	-4.8 %	$ 255 M	USA
Cara Therapeutics CARA	-94.17	-	-3.03 %	$ 260 M	USA
ChemoCentryx CCXI	-30.95	-	-	$ 3.74 B	USA
Aeglea BioTherapeutics AGLE	-19.95	-	-	$ 1.01 B	USA
Avid Bioservices CDMO	-41.82	-	-	$ 789 M	USA
CureVac N.V. CVAC	-35.55	-	-	$ 867 M	Germany
Bellerophon Therapeutics BLPH	-249.92	-	-74.18 %	$ 955 K	USA
Corbus Pharmaceuticals Holdings CRBP	-46.69	$ 8.31	1.59 %	$ 111 M	USA
CRISPR Therapeutics AG CRSP	-25.67	$ 47.09	1.42 %	$ 4.23 B	Schweiz
Arbutus Biopharma Corporation ABUS	-35.41	$ 4.53	5.1 %	$ 868 M	Canada
AIkido Pharma AIKI	-31.2	-	1.93 %	$ 17.4 M	USA
Allakos ALLK	-76.23	-	-	$ 28.6 M	USA
Brickell Biotech BBI	-49.15	-	-5.38 %	$ 6.06 M	USA
CytomX Therapeutics CTMX	-11.46	$ 4.22	-0.47 %	$ 582 M	USA
Allena Pharmaceuticals ALNA	-140.01	-	3.16 %	$ 1.9 M	USA
Calithera Biosciences CALA	-177.73	-	-10.95 %	$ 876 K	USA
Alpine Immune Sciences ALPN	-20.15	-	-	$ 2.17 B	USA
Cyclacel Pharmaceuticals CYCC	-273.86	-	-5.98 %	$ 34.1 M	USA